Oliceridine as a Novel Selective mu-receptor G-protein Pathway Modulator: A Narrative review
Objective: To review the literature on equianalgesic efficacy and better safety(less respiratory depression and gastrointestinal dysfunction) of oliceridine versus opioid analgesic in moderate to severe postoperative pain. Methodology: A comprehensive literature search was conducted in PubMed (Janu...
Format: | Article |
---|---|
Language: | English |
Published: |
Prathima Institute of Medical Sciences
2021-01-01
|
Series: | Perspectives In Medical Research |
Online Access: | https://pimr.org.in/2021-vol9-issue-3/1047799pimr090302-2021-12-28-06-42.pdf |
Similar Items
-
Journey of Oliceridine: A Novel Opioid
by: A Tejus, et al.
Published: (2022-01-01) -
Oliceridine for the Management of Moderate to Severe Acute Postoperative Pain: A Narrative Review
by: Daksla N, et al.
Published: (2023-03-01) -
Oliceridine and its potential to revolutionize GI endoscopy sedation
by: Basavana Goudra, et al.
Published: (2020-01-01) -
Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain – A Review of Current Evidence
by: Tan HS, et al.
Published: (2021-04-01) -
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy
by: Bergese SD, et al.
Published: (2019-11-01)